• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

HBV and HCV coinfection may increase non-Hodgkin’s lymphoma risk in HIV-infected patients

byEvelyn NguyenandDeepti Shroff Karhade
October 18, 2016
in Chronic Disease, Infectious Disease, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Compared to the HIV-negative population, chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection was found to be associated with a greater risk for non-Hodgkin lymphoma (NHL) in HIV-infected patients receiving antiretroviral therapy (ART).

2. To reduce morbidity and mortality from NHL in HIV-infected patients, it is important that HIV infection be diagnosed and treated early and for routine HBV and HCV screenings to be done.

Evidence Rating Level: 1 (Excellent)          

Study Rundown: Compared to the HIV-negative population, people infected with HIV have an incidence rate of NHL that is approximately 10 times greater.  Chronic HBV and HCV coinfection is suspected to be associated with NHL in HIV-negative people.  It is unclear if this association also exists in the HIV-infected population.  To examine whether or not there was such an association, this prospective cohort study followed 52 479 patients from 18 of 33 cohorts from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE).  Compared to the HIV-negative population, chronic HBV and HCV coinfection was found to be associated with a greater risk for NHL in HIV-infected patients receiving ART.  Therefore, to reduce morbidity and mortality from NHL in HIV-infected patients, it is important that HIV infection be diagnosed and treated early and for routine HBV and HCV screenings to be done.

A key strength of the study was that this was the first large prospective cohort study that found an association between NHL and chronic HBV and HCV coinfection in HIV-infected patients.  Past studies that did not find such an association were case-control studies or cohort studies of a smaller scale.  One limitation of the study was that the analysis was restricted to the patients from COHERE who provided information regarding chronic HBC and HCV infection.  In addition, screening and data collection for HBV and HCV coinfection were not ideal.  Thirdly, it is possible that reactivation of HBV in extremely immunosuppressed patients receiving ART or resistance of HBV to lamivudine could have be a reason for the increased risk for NHL that was detected in patients who were coinfected.  Also, NHL cases were merged due to NHL type being unclassified for a large number of cases, which meant that analysis by NHL subtype was not possible.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy

RELATED REPORTS

Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir

Several factors influence health programs conducted in the African American Church

#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

In-Depth [prospective cohort]:  This study followed 52 479 patients who were treatment-naïve, including 1339 who had chronic HBV infection, 7506 who had chronic HCV infection, and 210 who were infected with both.  ART was later started by 40 219 of these patients.  Patients were studied during the time that they were ART-naïve and during ART therapy (if treatment was started).  The main outcome studied was the time period until NHL diagnosis.  ART-naïve patients and ART-treated patients had a median follow-up of 13 months and 50 months, respectively.  During the time of follow-up, 252 ART-naïve patients and 310 ART-treated patients were diagnosed with NHL.  Per 100 000 person-years, the incidence rates were 219 and 168 cases, respectively.  Chronic HBV and HCV coinfection was found to be associated with a greater risk for NHL in HIV-infected patients receiving antiretroviral therapy (ART) compared to the HIV-negative population.  Estimates in patients who were ART-naïve were unclear due to insufficient power.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: hepatitis bhepatitis CHIVNon-Hodgkin Lymphoma
Previous Post

Patients hospitalized for accidental firearm injuries more likely to have a violence-related arrest

Next Post

Acute caffeine ingestion does not increase arrhythmias in patients with chronic systolic heart failure

RelatedReports

Gardasil vaccine demonstrates immunogenic response at 10-year follow-up
Chronic Disease

Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir

May 18, 2022
Wellness

Several factors influence health programs conducted in the African American Church

May 18, 2022
#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
StudyGraphics

#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

April 23, 2022
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men
Chronic Disease

Liposomal amphotericin B noninferior to standard treatment for cryptococcal meningitis

March 29, 2022
Next Post
Cognitive behavioral therapy effective for insomnia with medical or psychiatric comorbidities

Acute caffeine ingestion does not increase arrhythmias in patients with chronic systolic heart failure

Significant healthcare disparities exist between rural and non-rural children

Early corticosteroid therapy associated with better outcomes in Kawasaki Disease

ACP releases practice guidelines for the evaluation of suspected acute pulmonary embolism

Frequency of pulmonary embolism amongst patients admitted for first-time syncope

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.